Hong Kong IPO At A Glance: SenseTime Group
Date
12/6/2021 3:27:08 AM
(MENAFN- ValueWalk)
SenseTime received approval to list on the Hong Kong stock exchange on November 19, 2021.
Get Our Icahn eBook!
Get our entire 10-part series on Carl Icahn and other famous investors in PDF for free! Save it to your desktop, read it on your tablet or print it! Sign up below. NO SPAM EVER
Q3 2021 hedge fund letters, conferences and more
The Man Behind TCI: One Of The World's Top-Performing Hedge Funds
The Children's investment Fund Management LLP is a London-based hedge fund firm better known by its acronym TCI. Founded by Sir Chris Hohn in 2003, the fund has a global mandate and supports the Children's Investment Fund Foundation (CIFF). Q3 2021 hedge fund letters, conferences and more The CIFF was established in 2002 by Hohn Read More
SenseTime At A Glance
SenseTime is Asia's largest AI company (by revenue in 2020). It serves over 2,400 customers, including half of the Fortune 500 list. Here are a few business highlights:
- SenseTime markets its universal AI infrastructure across several industries, which allows it to develop cross-functional technological expertise.
- The company's revenue and gross profit margin have been growing, with the latter being among the lowest in the industry.
- The computer vision software industry is growing at a nearly 40% CAGR; with multiple patents, SenseTime remains highly competitive.
- Tech upgrades of China's major cities boost SenseTime's revenue, but the company should keep entering other application fields to keep growing.
Article by Tzuhsuan Tang, EqualOcean , an investment research firm focusing on China.
Updated on Dec 3, 2021, 12:43 pm
MENAFN06122021005205011743ID1103310510
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.